-+ 0.00%
-+ 0.00%
-+ 0.00%

ULTRAGENYX PHARMACEUTICAL - MHRA ACCEPTS ULTRAGENYX MAA FOR REBISUFLIGENE ETISPARVOVEC (UX111) ON OCT 28, 2026

Reuters·11/06/2026 08:30:14

Please log in to view news